is hair loss common with tirzepatide Does Cause Loss? Does Tirzepatide Cause Hair Loss?

June 1, 2026: Depo-Provera Brain Tumor MDL Grows to Over 5,500 Claims As of June 1, 2026, there are 5,508 lawsuits in the MDL that accuse Pfizer and several other companies of failing to warn women that Depo-Provera use may increase their chance of developing a brain tumor

Microdosing as an Entry Point or Exit Strategy Chris Michaelis, DO, owner of Luminus Aesthetics, said microdosing often serves as an entry point or an exit strategy, depending on the patient

Light protection: Keep the vial in its original packaging or wrapped in foil

It may reduce cravings, but studies havent shown a clear benefit for weight loss

The exercise intervention resulted in a significantly slower decline of eGFR (calculated using cystatin-C levels) over two years compared with health education alone

While orforglipron is not a peptide, it can activate the glucagon-like peptide-1 receptor in the same way as GLP-1 medications